Snake Venoms Cause and Block Pain

Painful snake bites may hold clues to developing analgesic drugs.

Written byKerry Grens
| 2 min read
The Black Mamba is the longest, fastest and most dangerous venomous snake of Africa.
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Snakes represent some of the deadliest venomous animals in the world, killing between 81,000 and 138,000 people each year, according to the World Health Organization. But in low doses, some of their toxins can produce analgesia.

For instance, a toxin from the black mamba (Dendroaspis polylepis) inhibits pain by blocking acid-sensing ion channels on the surface of pain-transmitting neurons in mice (Nature, 490:552-55, 2012). Another compound, taken from the venom of the king cobra (Ophiophagus hannah), likewise diminishes pain but acts in an unusual way. R. Manjunatha Kini of the National University of Singapore has found that so-called hannalgesin likely disrupts nitric oxide synthase in neurons, thereby reducing nitric oxide production, which is involved in pain. “There are many ways of skinning a cat, and there could be many ways to block pain,” says Kini.

Although both toxins helped launch companies looking to develop analgesics in recent years, neither progressed, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Published In

January 2018

The Science of Pain

New research on an age-old ailment

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies